APOE and Alzheimer disease: It is also important to note that approximately 30% of patients with AD are non-apoE4 carriers [84] and that regardless of one’s apoE subtype, abilities of OLs to form and maintain healthy myelin sheaths eventually decline along with natural aging [85].